Aerosolized anticoagulants ameliorate acute lung injury in sheep after exposure to burn and smoke inhalation - PubMed (original) (raw)
Aerosolized anticoagulants ameliorate acute lung injury in sheep after exposure to burn and smoke inhalation
Perenlei Enkhbaatar et al. Crit Care Med. 2007 Dec.
Abstract
Objective: Acute lung injury is a detrimental complication for victims of burn accidents. Airway obstruction plays an important role in pulmonary dysfunction in these patients. In this study, we tested the hypothesis that aerosolized anticoagulants will reduce the degree of airway obstruction and improve pulmonary function in sheep with severe combined burn and smoke inhalation injury by preventing the formation of airway fibrin clots.
Design: Prospective, randomized, controlled, experimental animal study.
Setting: Investigational intensive care unit at a university hospital.
Subjects: Adult female sheep.
Interventions: After 7 days of surgical recovery, sheep were given a cutaneous burn (40% of total body surface, third degree) and insufflated with cotton smoke (48 breaths, <40 degrees C) under halothane anesthesia. After injury, sheep were placed on ventilators and resuscitated with lactated Ringer's solution. Sheep were randomly divided into five groups: sham, noninjured and nontreated (n = 6); control, injured and aerosolized with saline (n = 6); recombinant human antithrombin (rhAT) + heparin, injured and aerosolized with rhAT (290 units for each) and heparin (10,000 units for each) (n = 6); rhAT, injured and aerosolized with rhAT alone (290 units for each; n = 5); and heparin, injured and aerosolized with heparin alone (10,000 units for each; n = 5). rhAT and heparin were aerosolized every 4 hrs, starting at 2 hrs postinjury.
Measurements and main results: Cardiopulmonary hemodynamics were monitored during a 48-hr experimental time period. Control sheep developed multiple signs of acute lung injury. This pathophysiology included decreased pulmonary gas exchange and lung compliance, increased pulmonary edema, and extensive airway obstruction. These variables were stable in sham animals. The aerosolization of rhAT or heparin alone did not significantly improve deteriorated pulmonary gas exchange. However, aerosolization of these anticoagulants in combination significantly attenuated all the observed pulmonary pathophysiology.
Conclusions: The results provide definitive evidence that aerosolized rhAT and heparin in combination may be a novel treatment strategy for pulmonary pathology in burn victims with smoke inhalation injury.
Similar articles
- Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation.
Enkhbaatar P, Esechie A, Wang J, Cox RA, Nakano Y, Hamahata A, Lange M, Traber LD, Prough DS, Herndon DN, Traber DL. Enkhbaatar P, et al. Clin Sci (Lond). 2008 Feb;114(4):321-9. doi: 10.1042/CS20070254. Clin Sci (Lond). 2008. PMID: 17927568 - Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury.
Enkhbaatar P, Connelly R, Wang J, Nakano Y, Lange M, Hamahata A, Horvath E, Szabo C, Jaroch S, Hölscher P, Hillmann M, Traber LD, Schmalstieg FC, Herndon DN, Traber DL. Enkhbaatar P, et al. Crit Care Med. 2009 Jan;37(1):208-14. doi: 10.1097/CCM.0b013e318193226a. Crit Care Med. 2009. PMID: 19050603 Free PMC article. - The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury.
Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, Traber L, Phillips GB, Parkinson JF, Cox R, Hawkins H, Herndon D, Traber D. Enkhbaatar P, et al. Am J Respir Crit Care Med. 2003 Apr 1;167(7):1021-6. doi: 10.1164/rccm.200209-1031PP. Am J Respir Crit Care Med. 2003. PMID: 12663341 - Pathophysiology of acute lung injury in combined burn and smoke inhalation injury.
Enkhbaatar P, Traber DL. Enkhbaatar P, et al. Clin Sci (Lond). 2004 Aug;107(2):137-43. doi: 10.1042/CS20040135. Clin Sci (Lond). 2004. PMID: 15151496 Review. - Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.
Miller AC, Elamin EM, Suffredini AF. Miller AC, et al. Crit Care Med. 2014 Feb;42(2):413-9. doi: 10.1097/CCM.0b013e3182a645e5. Crit Care Med. 2014. PMID: 24158173 Free PMC article. Review.
Cited by
- Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats.
Camprubí-Rimblas M, Tantinyà N, Guillamat-Prats R, Bringué J, Puig F, Gómez MN, Blanch L, Artigas A. Camprubí-Rimblas M, et al. J Thromb Haemost. 2020 Mar;18(3):571-583. doi: 10.1111/jth.14685. Epub 2019 Dec 16. J Thromb Haemost. 2020. PMID: 31755229 Free PMC article. - [Pathophysiology of acute lung injury in severe burn and smoke inhalation injury].
Maybauer MO, Rehberg S, Traber DL, Herndon DN, Maybauer DM. Maybauer MO, et al. Anaesthesist. 2009 Aug;58(8):805-12. doi: 10.1007/s00101-009-1560-x. Anaesthesist. 2009. PMID: 19517070 Review. German. - Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide.
Rancourt RC, Veress LA, Guo X, Jones TN, Hendry-Hofer TB, White CW. Rancourt RC, et al. Am J Physiol Lung Cell Mol Physiol. 2012 Jan 1;302(1):L82-92. doi: 10.1152/ajplung.00306.2010. Epub 2011 Sep 30. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 21964405 Free PMC article. - Pathophysiology, research challenges, and clinical management of smoke inhalation injury.
Enkhbaatar P, Pruitt BA Jr, Suman O, Mlcak R, Wolf SE, Sakurai H, Herndon DN. Enkhbaatar P, et al. Lancet. 2016 Oct 1;388(10052):1437-1446. doi: 10.1016/S0140-6736(16)31458-1. Lancet. 2016. PMID: 27707500 Free PMC article. Review. - HEPBURN - investigating the efficacy and safety of nebulized heparin versus placebo in burn patients with inhalation trauma: study protocol for a multi-center randomized controlled trial.
Glas GJ, Muller J, Binnekade JM, Cleffken B, Colpaert K, Dixon B, Juffermans NP, Knape P, Levi MM, Loef BG, Mackie DP, Malbrain M, Schultz MJ, van der Sluijs KF. Glas GJ, et al. Trials. 2014 Mar 25;15:91. doi: 10.1186/1745-6215-15-91. Trials. 2014. PMID: 24661817 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical